Clinical trials play an important role in developing new treatments for eye diseases, but many people aren’t sure what they involve. Learn how these studies work and how they contribute to advancing eye care.
Clinical trials are research studies in which scientists test how well a medical, surgical, or behavioral intervention works in people. Clinical trials are the safest known approach for finding safe and effective treatments and therapies to fight eye disease.*
These trials take place at study centers across the country and are led by study-approved doctors. Conducted in four phases, they follow strict standards set by the U.S. Food and Drug Administration (FDA) to ensure safety and accuracy:
In some cases, dose-ranging or dose-escalation trials may be executed to help decide the best drug dosage and if there are side effects. This involves all participants receiving the treatment or therapy but in differing amounts.
Improvement of your eye condition or disease is not guaranteed through participation, and sometimes the anticipated results do not occur. Statistics show that less than half of experimental clinical trials complete both Phase 1 and II studies, and some treatments being tested come with side effects. These side effects will be monitored and studied by the researchers.
To get started in finding a clinical trial, you should begin with the following:
Clinical trials can be found at www.clinicaltrials.gov or www.centerwatch.com. Also, your doctor may know of studies being conducted for your particular condition.
Once you find a study, ensure you meet specific criteria, which will be found in each study recruitment announcement.
After you find the right fit and determine your eligibility, you will want to contact the trial center using the contact information that appears on the recruitment announcement. If the trial center also confirms you meet their criteria, you will be asked to attend an appointment where you may undergo a physical exam or other eligibility tests.
Prior to beginning participation in a study, be sure to talk to your healthcare provider about any risks and potential benefits.
You may be randomly assigned to either an experimental group, which means you receive the treatment or therapy that is being tested, or the control group, which means you receive an existing treatment, a placebo, or no treatment at all. When you’re officially a part of the clinical trial, it’s important to follow the protocol that the doctor describes.
Depending on the study design, you may not know which group you are assigned to, particularly if it is double-masked (where neither you nor the practitioner knows what treatment you’re receiving) or single-masked (where your practitioner knows which treatment you’re receiving, but you do not). In an open-label study, both the doctor and study participant know the treatment being received.
Once you thoroughly understand the details of the study, you will need to sign a consent form so you can participate and so that your learned data can be shared to find an effective new therapy.
By being a part of a clinical trial for eye diseases and conditions, you are advancing medicine so that new treatments and therapies, and sometimes cures, are available to many people who are suffering. Without your participation in clinical trials, better vision health for the future would not be a possibility.
*West, K. (2020, July 1). Clinical Trials for Eye Diseases and Vision. Prevent Blindness. https://preventblindness.org/clinical-trials-for-eye-diseases-and-vision/
Source: {{articlecontent.article.sourceName}}
Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!
Already a Responsum member?
Available for Apple iOS and Android
Add Comments
Cancel